Skip to main content
  • Onyx is associated with poor venous penetration in the treatment of spinal dural arteriovenous fistulas

    Final Number:
    1278

    Authors:
    Kristopher Gray Hooten MD; Spiros L. Blackburn MD; Wilson Zachary Ray MD; Gregory J. Zipfel MD; DeWitte T. Cross MD; Christopher J. Moran MD; Colin Derdeyn MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Onyx has become a preferred treatment for cranial dural arteriovenous fistulas (cDAVFs) and arteriovenous malformations (AVMs), but the reported success for Type I spinal AVFs (sDAVF) remains limited. We review our experience with Onyx and report its limitations in the treatment of spinal AVFs in comparison to n-butyl cyanoacrylate (NBCA).

    Methods: We retrospectively reviewed the Interventional Neuroradiology procedure database at Washington University for cases of sDAVF embolization. Patient charts and radiology reports were reviewed for fistula classification, treatment technique, and initial and follow-up results. Angiographic images were reviewed to confirm diagnosis, treatment and penetration of embolisate into the draining vein.

    Results: From 2006 to 2011, a total of 20 patients with sDAVFs were treated via endovascular embolization. Seven patients were treated with Onyx, and 13 with NBCA. For type I AVF there were 9 treatments (7 patients) with Onyx and 10 treatments (10 patients) with NBCA. Of the 9 total treatments, Onyx successfully crossed the nidus into the draining vein in only 4 cases. Successful venous embolization was facilitated with positioning of the microcatheter to less than 5mm from the nidus in 3 of the 4 cases. The use of NBCA resulted in venous penetration in 8 of 10 cases, and short-term follow-up cure in 7 of 10.

    Conclusions: Our experience with Onyx for Type I sDAVF embolization has been tempered by difficulty achieving venous penetration and consequently, a high rate of recurrence. For endovascular management of these fistulas, we favor NBCA or surgical treatment.

    Patient Care: Offers another perspective in embolization of spinal AVF

    Learning Objectives: Treatment of spinal AV fistulas

    References: 1. Natarajan SK, Ghodke B, Kim LJ, Hallam DK, Britz GW, Sekhar LN. Multimodality treatment of intracranial dural arteriovenous fistulas in the Onyx era: a single center experience. World Neurosurg;73:365-379 2. Maimon S, Nossek E, Strauss I, Blumenthal D, Frolov V, Ram Z. Transarterial treatment with Onyx of intracranial dural arteriovenous fistula with cortical drainage in 17 patients. AJNR Am J Neuroradiol;32:2180-2184 3. Macdonald JH, Millar JS, Barker CS. Endovascular treatment of cranial dural arteriovenous fistulae: a single-centre, 14-year experience and the impact of Onyx on local practise. Neuroradiology;52:387-395 4. Long XA, Karuna T, Zhang X, Luo B, Duan CZ. Onyx embolisation of dural arteriovenous fistula via arterial and venous pathways: preliminary experience and evaluation of the short-term outcomes. Br J Radiol 5. De Keukeleire K, Vanlangenhove P, Kalala Okito JP, Hallaert G, Van Roost D, Defreyne L. Transarterial embolization with ONYX for treatment of intracranial non-cavernous dural arteriovenous fistula with or without cortical venous reflux. J Neurointerv Surg;3:224-228

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy